BNP Paribas Financial Markets’s Eton Pharmaceutcials ETON Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.25M | Buy |
87,696
+48,379
| +123% | +$689K | ﹤0.01% | 2092 |
|
2025
Q1 | $510K | Buy |
39,317
+38,967
| +11,133% | +$506K | ﹤0.01% | 2384 |
|
2024
Q4 | $4.66K | Hold |
350
| – | – | ﹤0.01% | 4087 |
|
2024
Q3 | $2.1K | Hold |
350
| – | – | ﹤0.01% | 3160 |
|
2024
Q2 | $1.15K | Hold |
350
| – | – | ﹤0.01% | 3177 |
|
2024
Q1 | $1.31K | Hold |
350
| – | – | ﹤0.01% | 3173 |
|
2023
Q4 | $1.53K | Hold |
350
| – | – | ﹤0.01% | 3104 |
|
2023
Q3 | $1.46K | Hold |
350
| – | – | ﹤0.01% | 3046 |
|
2023
Q2 | $1.22K | Hold |
350
| – | – | ﹤0.01% | 3129 |
|
2023
Q1 | $1.35K | Hold |
350
| – | – | ﹤0.01% | 3029 |
|
2022
Q4 | $987 | Hold |
350
| – | – | ﹤0.01% | 3141 |
|
2022
Q3 | $735 | Hold |
350
| – | – | ﹤0.01% | 3764 |
|
2022
Q2 | $917 | Hold |
350
| – | – | ﹤0.01% | 3271 |
|
2022
Q1 | $1.53K | Sell |
350
-358
| -51% | -$1.56K | ﹤0.01% | 3360 |
|
2021
Q4 | $3.04K | Sell |
708
-57
| -7% | -$245 | ﹤0.01% | 3315 |
|
2021
Q3 | $3.86K | Sell |
765
-868
| -53% | -$4.38K | ﹤0.01% | 3128 |
|
2021
Q2 | $10.1K | Sell |
1,633
-526
| -24% | -$3.24K | ﹤0.01% | 3125 |
|
2021
Q1 | $15.8K | Sell |
2,159
-788
| -27% | -$5.77K | ﹤0.01% | 3221 |
|
2020
Q4 | $24K | Sell |
2,947
-201
| -6% | -$1.63K | ﹤0.01% | 3152 |
|
2020
Q3 | $24.9K | Buy |
3,148
+2,596
| +470% | +$20.5K | ﹤0.01% | 3131 |
|
2020
Q2 | $3.01K | Buy |
+552
| New | +$3.01K | ﹤0.01% | 3507 |
|